Back to Home

OIG Oversight

Expert articles and analysis related to oig oversight.

112 articles‱Last 7 Days

AI Summary — Last 7 Days

In the past week, significant actions have unfolded in the Medicare Advantage landscape, underscoring ongoing compliance scrutiny. Aetna has agreed to pay $117.7 million to settle allegations of fraudulent billing practices related to its Medicare Advantage plans, reflecting the heightened oversight by CMS and the Office of Inspector General (OIG) aimed at addressing upcoding issues. Additionally, the OIG has drawn attention to compliance risks associated with specific diagnosis codes submitted by Blue Cross and Blue Shield of Alabama, indicating that such oversight is becoming a central focus of CMS and the evolving Medicare compliance framework. These developments signal a tightening regulatory environment that aims to uphold the integrity of Medicare Advantage programs, posing implications for value-based care strategies employed by ACOs and health systems navigating payment transformations. For further details, see the OIG report on Medicare Advantage compliance

Related Articles

90ALN

CMS announces centralized platform for managing independent dispute resolution operations

CMS announces centralized platform for managing independent dispute resolution operations  American Hospital Association

aha.orgMar 16, 2026
90ALN

Epic flags improper access to UPMC records

Epic flags improper access to UPMC records - Becker's Hospital Review  Becker's Hospital Review

beckershospitalreview.comMar 16, 2026
90ALN

How Stark law becomes an ‘insurmountable barrier’ to patient care

For patients facing low health literacy and significant social determinants of health challenges, navigating the healthcare system can be difficult even under the best circumstances. But according to ...

beckersasc.comMar 16, 2026
90ALN

GAO Rejects Unequal Evaluation Claim In CMS Contract

GAO Rejects Unequal Evaluation Claim In CMS Contract  Law360

Law360Mar 16, 2026
90ALN

U.S. Attorney Announces Additional Enforcement Action as Part of National Effort to Combat Electrical Stimulation Fraud Scheme and Recover Millions - Office of Inspector General (.gov)

U.S. Attorney Announces Additional Enforcement Action as Part of National Effort to Combat Electrical Stimulation Fraud Scheme and Recover Millions  Office of Inspector General (.gov)

oig.hhs.govMar 16, 2026
90ALN

Owners and CEO of Wholesale Pharmaceutical Company Sentenced for Distributing More Than $92M of Black-Market HIV Drugs - Office of Inspector General (.gov)

Owners and CEO of Wholesale Pharmaceutical Company Sentenced for Distributing More Than $92M of Black-Market HIV Drugs  Office of Inspector General (.gov)

oig.hhs.govMar 16, 2026
90ALN

Advisory Opinion 26-05 - Office of Inspector General (.gov)

Advisory Opinion 26-05  Office of Inspector General (.gov)

oig.hhs.govMar 16, 2026
90ALN

Evaluation and Management Services on Same Day as Minor Surgery With No Modifier 25 - Office of Inspector General (.gov)

Evaluation and Management Services on Same Day as Minor Surgery With No Modifier 25  Office of Inspector General (.gov)

oig.hhs.govMar 16, 2026
90ALN

Oz pledges to tackle hospice fraud: 'Do not steal from the American people'

Oz pledges to tackle hospice fraud: 'Do not steal from the American people'  Health Leaders Media

healthleadersmedia.comMar 16, 2026
90ALN

Inpatient Claims for Neurostimulator Implantation Surgeries - Office of Inspector General (.gov)

Inpatient Claims for Neurostimulator Implantation Surgeries  Office of Inspector General (.gov)

oig.hhs.govMar 16, 2026